Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Nonhuman

Nitrogen oxides are generated by both human and nonhuman action, but the major sources of NO, are high-temperature combustion processes such as those occurring in power plants and automobile engines. Natural sources of NO., include lightning, chemical processes that occur in soil, and the metabolic activities of plants. [Pg.51]

Infectious non-communicable bioaerosols are airborne bacteria or fungi that can infect humans but that have a nonhuman source. [Pg.56]

Both globulins exert their effect by depletion of circulating lymphocytes either by complement-dependent lysis or by phagocytosis after opsonization. However, antilymphocyte globulin (ALG) and antithymocyte globulin (ATG) are nonhuman polyclonal antibodies. To prevent sensitization application is restricted to a time period of several days only. [Pg.619]

Muronomab-CD3 is a murine monoclonal antibody directed against the CD3 complex of the T-lymphocyte antigen receptor. This drug selectively diminishes the T-lymphocyte pool resulting in a strong lymphopenia. Similar to other nonhuman antibodies the generation of human antimurine antibodies (HAMA) limits its long-term use. [Pg.619]

Treatment with specific antibodies (ALG, ATG, anti-CD3, anti-CD25) is indicated during the induction phase after transplantation and in the case of acute rejection for short time periods. Therapy with nonhuman antibodies may cause sensitization. Muromonab-CD3 might initiate a cytokine release syndrome (fever, chills, headache). [Pg.621]

A synthetic neurotoxin that causes parkinsonism in human and nonhuman primates, mice, gold fish, and dogs. MPTP is inert but metabolized by MAO-B to the neurotoxin MPP+ (1,2-dihydropyridine ion). This neurotoxin causes depletion of dopamine and degeneration of nigrostriatal dopamine neurons similar to what is observed in Parkinson s disease. [Pg.793]

Reich DL, Silvay G Ketamine an update on the first twenty-five years of clinical experience. Can J Anaesth 36 186—197, 1989 Ricaurte GA, Forno LS, Wilson MA, et al (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260 51-55, 1988... [Pg.265]

Positron emission tomography studies using "C-toluene in nonhuman primates and mice showed a rapid uptake of radioactivity into striatal and frontal brain regions (Gerasimov et al. 2002). Maximal uptake of the radiotracer by these structures occurred 1 minutes after intravenous administration. Subsequently, clearance of the radiotracer from the striatal and frontal areas occurred rapidly, with a clearance half-life from peak uptake of 10—20 minutes. Radiotracer clearance from white matter appears to be slower... [Pg.274]

Ricaurte, G.A. Fomo, L.S. Wilson, M.A. DeLanney, L.E. Irwin, L. Molliver, M.E. and Langston, J.W. ( )-3,4-methylenedioxyamphetamine selectively damages central serotonergic neurons in nonhuman primates. [Pg.41]

Kitt, C.A. Walker, L.C. Molliver. M.E. and Price, D.L. Serotoninergic neurites in senile plaques in cingulate cortex of aged nonhuman primate. Synapse 3 12-18, 1989. [Pg.300]

Studies of MDMA-Induced Neurotoxicity in Nonhuman Primates A Basis for Evaluating Long-Term Effects in Humans... [Pg.306]

This chapter will review some recently completed studies on the long-term effects of MDMA in nonhuman primates. The goals of these studies were to (1) determine if the neurotoxic effects of MDMA, which have been well documented in the rodent (see below), generalize to the primate (2) compare the relative sensitivity of primates and rodents to the neurotoxic effects of MDMA (3) ascertain if the toxic effects of MDMA in the monkey are restricted to nerve fibers (as they are in the rat), or if they involve cell bodies as well (4) evaluate how closely toxic doses of MDMA in the monkey approximate those used by humans and (5) examine whether 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF) can be used to detect MDMA-induced serotonergic damage in the CNS of primates. Before presenting the results of these studies, previous results in the... [Pg.306]

Palmer 1989 Robinson et al.1983). However, the ratio was almost certainly affected by initial chelation with Ca-DPTA, followed by daily intravenous therapy with the chelating agent, Zn-DPTA, treatments that would have increased the urinary excretion of americium (Breitenstein and Palmer 1989). The above not withstanding, the observations made on this subject demonstrate that fecal excretion was an important pathway of excretion in this subject long after mechanical clearance of americium from the respiratory tract would have been complete. This is consistent with observations made in nonhuman primates that show that americium is excreted into bile (see Section 3.4.4.4). However, the extent to which the biliary excretion pathway in humans might resemble that of nonhuman primates is not known. [Pg.72]

Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R, Schwartz CJ. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 1988 27(11) 4162 1168. [Pg.224]

The available inhalation data for Durad MP280, Fyrquel 220, Cellulube 220, Skydrol 500B-4, and cyclotriphosphazene (reviewed in the next paragraph) are inadequate to derive intermediate-duration MRLs for these individual fluids, principally because the studies were conducted in species (rats or rabbits) that are generally considered to be insensitive to the delayed neurotoxicity of acute exposure to organophosphate esters. Cats, dogs, or nonhuman primates more accurately model the human expression of OPIDN than rats and rabbits, and studies in these species would provide a better basis for MRL derivation. [Pg.191]

Infection by viruses carrying oncogenes can cause malignant cell growth. Although first recognized as causative agents in avian cancers 90 years ago, for much of the twentieth century there was doubt that any human cancers were initiated in this way. Even now, almost all the information in this area refers to nonhuman animals, which presents a number of problems. First, as was already... [Pg.264]


See other pages where Nonhuman is mentioned: [Pg.142]    [Pg.198]    [Pg.167]    [Pg.123]    [Pg.123]    [Pg.448]    [Pg.49]    [Pg.240]    [Pg.694]    [Pg.411]    [Pg.433]    [Pg.789]    [Pg.128]    [Pg.290]    [Pg.327]    [Pg.261]    [Pg.46]    [Pg.165]    [Pg.357]    [Pg.31]    [Pg.70]    [Pg.196]    [Pg.306]    [Pg.307]    [Pg.342]    [Pg.348]    [Pg.55]    [Pg.183]    [Pg.14]    [Pg.547]    [Pg.273]   


SEARCH



Embryofetal development studies nonhuman primates

Findings in CR Nonhuman Primates

Nonhuman Species

Nonhuman animal testing

Nonhuman cells

Nonhuman milk

Nonhuman nature

Nonhuman primate Cynomolgus monkey

Nonhuman primates

Nonhuman primates animal models

Nonhuman primates cardiovascular safety

Nonhuman primates development

Nonhuman primates embryofetal development

Nonhuman primates immunotoxicity testing

Nonhuman primates monkeys

Nonhuman primates monoclonal antibodies

Nonhuman primates reproductive/developmental toxicity studies

Nonhuman primates toxicity studies, pharmacological activity

Nonhuman resources

Nonhuman world

Oligosaccharides of Nonhuman Milk Origin

Parkinson disease nonhuman primate models

Postnatal development studies nonhuman primates

Primate models nonhuman primates

The Lipopolysaccharides of Helicobacter Species from Nonhuman Primates

© 2024 chempedia.info